Omalizumab relieves seasonal asthma attacks in youth, study finds
Wednesday, March 16, 2011 - 18:30
in Health & Medicine
A drug that targets the antibody immunoglobulin E, a key player in asthma, nearly eliminated seasonal increases in asthma attacks and decreased asthma symptoms among young people living in inner city environments, a clinical trial has found.